Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. pediatric care
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Pediatric Care Articles & Analysis

27 news found

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines on asthma management. Bedfont® manufactures the NObreath® Fractional exhaled Nitric Oxide (FeNO) device, which aids in diagnosing ...

ByBedfont Scientific Limited


Bayer to present new cardiorenal data for Kerendia (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes

Bayer to present new cardiorenal data for Kerendia (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Kerendia (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study

Kerendia (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Kerendia (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

Kerendia (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

As an international reference center, located in the heart of the Brussels Region, the H.U.B offers high quality general, oncological and pediatric care. This excellent care, accessible to all, is enriched and sustained by a dual approach of scientific research and teaching for the caregivers of tomorrow. ...

ByNeutron Therapeutics, Inc.


Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

As an international reference center, located in the heart of the Brussels Region, the H.U.B offers high quality general, oncological and pediatric care. This excellent care, accessible to all, is enriched and sustained by a dual approach of scientific research and teaching for the caregivers of tomorrow. ...

ByNeutron Therapeutics, Inc.


Bayer receives approval in Japan for Kerendia (finerenone), a new treatment for adults with chronic kidney disease and type 2 diabetes

Bayer receives approval in Japan for Kerendia (finerenone), a new treatment for adults with chronic kidney disease and type 2 diabetes

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

“We are proud to support Urgent Care for Children in their efforts to address patients in need with accurate diagnostic results and proper treatment during that single visit.” About Urgent Care for Children Urgent Care for Children is a physician-founded pediatric urgent care provider with 20 clinics ...

ByVisby Medical, Inc.


Bayer’s new treatment Kerendia (finerenone) approved in EU for adult patients with chronic kidney disease associated with type 2 diabetes

Bayer’s new treatment Kerendia (finerenone) approved in EU for adult patients with chronic kidney disease associated with type 2 diabetes

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Bayer receives positive CHMP opinion for finerenone as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes

Bayer receives positive CHMP opinion for finerenone as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes

Having randomized more than 13,000 patients with CKD and T2D around the world, the Phase III program with finerenone in CKD and T2D comprises two completed and published studies, evaluating the effect of finerenone versus placebo on top of standard of care on both renal and cardiovascular outcomes. FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in ...

ByBayer AG


Hyperfine Partners With Madonna’s Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children

Hyperfine Partners With Madonna’s Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children

Hyperfine Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, today announced a partnership with Raising Malawi, which built and co-operates Malawi’s only specialized pediatric hospital, the Mercy James Centre for Paediatric Surgery & Intensive Care (MJC). ...

ByHyperfine


Protecting and preserving Carlton’s unique heritage

Protecting and preserving Carlton’s unique heritage

More than 20 new sites in Carlton have been identified for heritage protection, including the much-loved Lincoln Square, the Chinese Church of Christ and a former manufacturing building at RMIT University. Heritage portfolio lead Councillor Rohan Leppert said the Carlton heritage review is the latest in a series of independent expert reviews to identify and protect the city's heritage. "We've ...

ByCity of Melbourne


Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

For children and adolescents with chronic kidney disease (CKD), as for adults, the unmet need is high for new treatments to delay disease progression and preserve kidney function / The Phase III study FIONA will investigate the effect of finerenone in pediatric patients with CKD and severely increased proteinuria Bayer announced today the initiation of the FIONA study, a ...

ByBayer AG


OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications

OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications

Enables OrthoPediatrics to Further Address Full Patient Continuum of Care for Pediatric Orthopedic Surgeons with Market-Leading, Radiation-Free Navigation Technology WARSAW, Ind., Sept. 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the ...

By7D Surgical


Omega Medical Imaging Announces Installation of First AI Image-Guided Interventional Endoscopy System in Hawai’i

Omega Medical Imaging Announces Installation of First AI Image-Guided Interventional Endoscopy System in Hawai’i

Pali Momi Medical Center is the leader in health care for the people of Central and West Oahu. Their mission is to create a healthier Hawai’i. For Pali Momi, the health and safety of their patients, their care providers, and their staff is a top priority. The Medical Center provides exceptional care and strives to continuously improve that ...

ByOmega Medical Imaging, LLC.


HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)

HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)

Despite the current standard of care involving dietary control, carnitine supplementation and in more severe cases, organ transplantation, there remains a high unmet medical need in MMA and PA. ...

ByHemoShear Therapeutics, Inc.


Russian Regulatory Approval and Distribution for USCOM 1A

Russian Regulatory Approval and Distribution for USCOM 1A

Russian regulatory certification for USCOM 1A Cardiac Output Monitor, Russia a significant and growing European market, Uscom continues global expansion. USCOM 1A has received Russian Certification of Registration for sale into the Russian market. The regulatory process is usually 12-18 months but took approximately 3 years following delays with the COVID pandemic. Uscom has worked closely with ...

ByUscom Ltd


Riello UPS supports Emergency’s new children’s hospital

Riello UPS supports Emergency’s new children’s hospital

It was designed and engineered by renowned Italian architect Renzo Piano. The Pediatric Surgery Center of Entebbe (Uganda) represents a virtuous model for the entire African continent: it operates according to the EMERGENCY healthcare model based on the principles of Equality, Quality and Social Responsibility (EQS) and the guarantee of free high-level pediatric ...

ByRiello UPS Spa


HD Medical’s HD Steth Screens Over 50,000 Children for Congenital Heart Defects

HD Medical’s HD Steth Screens Over 50,000 Children for Congenital Heart Defects

The absence of early screening and sophisticated pediatric care is causing over 250 deaths among children every day in India. ...

ByHD Medical, Inc.


First use of nView’s novel 3D imaging technology in pediatric spine surgery

First use of nView’s novel 3D imaging technology in pediatric spine surgery

NCC-PDI is one of five members in the FDA’s Pediatric Device Consortia Grant Program created to support the development and commercialization of medical devices for children in areas of critical need where innovation can significantly improve children's health care. “Children deserve to benefit from our most advanced medical technologies and we know ...

BynView medical Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT